NovaBridge Biosciences (NBP) Depreciation & Amortization (CF) (2019 - 2025)
NovaBridge Biosciences (NBP) posted quarterly Depreciation & Amortization (CF) of $15000.0 for Q4 2025, down 31.82% year-over-year from $22000.0 in Q4 2024, and down 11.76% quarter-over-quarter from $17000.0 in Q3 2025.
Powered by 
Analysis
NovaBridge Biosciences (NBP) Depreciation & Amortization (CF) (2019 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Depreciation & Amortization (CF) for 4 consecutive years, with $15000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Depreciation & Amortization (CF) fell 31.82% year-over-year to $15000.0; the TTM figure through Dec 2025 stood at $32000.0 (down 23.81% YoY), while the FY2025 annual figure was $68000.0, down 77.33% from the prior year.
- Depreciation & Amortization (CF) slipped to $15000.0 in Q4 2025 per NBP's latest filing, from $17000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $22000.0 in Q4 2024 and bottomed at $15000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 40.52 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | NovaBridge Biosciences | 197.68 Mn | 197.68 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 15,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Dec 31, 2020 | 755,220.95 |
| Sep 30, 2020 | 382,291.49 |
| Dec 31, 2019 | 425,074.79 |